trial

Non-Invasive Brain Stimulation for Medication-Resistant Auditory Hallucinations in Schizophrenia Patients

NCTId NCT02240446
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Withdrawn
Enrollment 0 (actual)
Sponsored by University of Minnesota
Primary completion 2017-12
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Withdrawn
Enrollment
0 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2013-06
Primary completion
2017-12
Eligibility
ALL · 18 Years · 45 Years

Interventions & indications

Drugs
Active TDCS

Sponsors

University of MinnesotaLead Sponsor

Investigators

2
Jazmin Camchong, PhDPrincipal Investigator
Kelvin O Lim, MDPrincipal Investigator

Sites

1 total
Minneapolis, United States

Facts & assertions

4 sourced
Enrollment
0
Phase
NA
Primary Completion Date
2017-12
Status
WITHDRAWN
relationships
The graph out of here
drug
Active TDCS
drug
lead_sponsor
University of Minnesota
company
indication
Schizophrenia
indication
Hallucinations
indication
Auditory Hallucinations
indication
investigator
Jazmin Camchong, PhD
person
Kelvin O Lim, MD
person